To study the role of Eladi Kwatha with Sharkara and Madhu in atyadhik yonigata raktastrava with special reference to Abnormal uterine bleeding
- Conditions
- Health Condition 1: E349- Endocrine disorder, unspecified
- Registration Number
- CTRI/2021/05/033360
- Lead Sponsor
- Kalyani Mitalkumar Mahajan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients between the age group 15-45 yrs
Both married and unmarried women
Patients having Abnormal Uterine Bleeding with excessive and prolonged menstrual bleeding
Patients taking anti coagulation therapy and having any coagulation
defect.
Patients with severe malnutrition and severe anemia (Hb <= 8 gm/dl).
Threatened, spontaneous or incomplete abortion/ectopic pregnancy,
trophoblastic diseases, placental abnormalities and Antepartum
Hemorrhage.
Patients with systemic diseases like uncontrolled D.M. and T.B.
History of documented vascular disease like coronary artery disease,
cerebrovascular disease or stroke, transient ischemic attack, peripheral
vascular disease and DVT.
Condition like endometrial cancer of cervix, etc.
Bleeding from Reproductive Track due to traumatic causes, motor vehicle
accident and IC
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the efficacy of Eladi Kwatha with Sharkara and Madhu in <br/ ><br>Yonipravaha. <br/ ><br>Timepoint: day 1 to day 5 of Abnormal uterine bleeding
- Secondary Outcome Measures
Name Time Method Adverse effect of drug Eladi Kwatha with Sharkara and Madhu will be <br/ ><br>observed during clinical study, if any.Timepoint: 18 months of study period